Adhesion Barrier Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product (Synthetic Adhesion Barriers (Hyaluronic Acid, Regenerated Cellulose, Polyethylene Glycol, Others), Natural Adhesion Barrier (Collagen & Protein, Fibrin )), By Formulation (Film/Mesh, Gel, Liquid), By Application (Gynecological Surgeries, Abdominal General Surgeries, Orthopedic
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationAdhesion Barrier Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product (Synthetic Adhesion Barriers (Hyaluronic Acid, Regenerated Cellulose, Polyethylene Glycol, Others), Natural Adhesion Barrier (Collagen & Protein, Fibrin )), By Formulation (Film/Mesh, Gel, Liquid), By Application (Gynecological Surgeries, Abdominal General Surgeries, Orthopedic
| Forecast Period | 2024-2028 |
| Market Size (2022) | USD 724.89 million |
| CAGR (2023-2028) | 5.54% |
| Fastest Growing Segment | Synthetic adhesion barrier segment |
| Largest Market | North America |
Market Overview
Global Adhesion Barrier Market has valued at USD 724.89 million in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 5.54% through 2028. An adhesion barrier is a medical device used in surgery to prevent the formation of adhesions between tissues and organs. Adhesions are bands of scar tissue that can develop after surgical procedures, injury, or inflammation. These adhesions can cause tissues that are not normally connected to become bound together, potentially leading to complications and discomfort for the patient. Adhesion barriers are designed to create a physical barrier between tissues during the healing process after surgery. This barrier helps prevent the adhesion of tissues that can lead to complications such as pain, bowel obstruction, infertility, and other issues. Adhesion barriers are typically made from biocompatible materials that are safe for use within the body. The primary goal of using adhesion barriers is to improve patient outcomes by reducing the risk of complications associated with post-operative adhesions. Adhesion barriers can contribute to shorter hospital stays, faster recovery times, and fewer readmissions due to complications. The trend towards minimally invasive surgical approaches requires adhesion barriers that can be applied through smaller incisions while still effectively preventing adhesions. As these techniques become more popular, the demand for compatible adhesion barriers grows. The global aging population is a significant driver of surgical procedures, especially those associated with age-related conditions. This demographic trend contributes to the demand for adhesion barriers. Hospitals and healthcare providers are increasingly focused on reducing post-operative complications to improve patient satisfaction and minimize additional healthcare costs. Adhesion barriers play a role in achieving this objective.
Key Market Drivers
Growing Global Aging Population
Increasing Adhesion-Related Complications
Adhesion-related complications refer to medical issues that arise due to the formation of adhesions within the body. Adhesions are bands of scar tissue that form between tissues and organs, often because of surgical procedures, injury, or inflammation. These adhesions can cause tissues that are not normally connected to become bound together. Adhesion-related complications can lead to a range of symptoms and health problems, depending on their location and severity. It can form after surgical procedures as part of the body's natural healing process. They can also develop because of infections, inflammation, trauma, or radiation therapy. It can also occur in various parts of the body, such as the abdominal cavity, pelvis, joints, and even internal organs. In the context of surgical procedures, abdominal and pelvic adhesions are particularly common. Adhesion can lead to chronic pain in the affected area. In the abdominal cavity, adhesion can cause the intestines to become twisted or blocked, leading to bowel obstruction and severe pain. Pelvic adhesions can affect reproductive organs and lead to fertility problems. Adhesions can make subsequent surgeries more difficult and increase the risk of injury to surrounding tissues and organs and Adhesions around joints can restrict movement and cause discomfort. symptoms of adhesion-related complications vary depending on the location and severity of the adhesions. Common symptoms include abdominal pain, bloating, changes in bowel habits, infertility, and difficulty moving certain body parts. Adhesion prevention is an essential consideration in surgical procedures. Surgeons may use adhesion barriers, such as films, meshes, or gel-like substances, to create a physical barrier between tissues and prevent the formation of adhesions during the healing process. Treatment options for adhesion-related complications depend on the specific issue. Conservative approaches may include pain management and dietary adjustments for bowel-related issues. Surgical interventions may be required to remove adhesions in cases of severe complications. Adhesion-related complications are important to consider when planning and performing surgical procedures. Surgeons take precautions to minimize the risk of adhesions and address them promptly if they occur. Medical researchers and companies are continuously working on developing improved methods for preventing and managing adhesion-related complications. This includes the development of advanced adhesion barriers and minimally invasive techniques. This factor will pace up the demand of the Global Adhesion Barrier Market.
Rising Demand of Minimally Invasive Procedures
Minimally invasive surgical techniques, also known as minimally invasive surgery (MIS), involve performing surgical procedures with smaller incisions compared to traditional open surgery. In Minimally invasive surgery specialized instruments are inserted to perform the procedure. While these smaller incisions are associated with less tissue trauma compared to traditional open surgery, they still pose a risk of tissue adhesion. Adhesion barriers are used to create a barrier between tissues and organs, preventing them from sticking together as they heal. These techniques utilize specialized instruments, cameras, and advanced imaging technology to visualize and access the surgical site. Adhesion barriers are designed to be easily launched through small incisions. This is essential for minimally invasive surgery, where the size of the incision is a key factor in reducing patient discomfort and promoting quicker recovery. In laparoscopic surgery, a few small incisions are made in the abdomen, through which specialized instruments and a camera (laparoscope) are inserted. The surgeon views the surgical site on a monitor and performs the procedure using these instruments. Robot-assisted surgery involves a robotic system controlled by the surgeon. The surgeon operates from a console, manipulating robotic arms with precision. This approach is often used for complex procedures that require high precision. Endoscopic procedures involve the insertion of a thin, flexible tube (endoscope) with a camera and light source through small incisions or natural body openings. This allows the surgeon to visualize and operate internally without larger incisions. Arthroscopy is used for joint-related procedures. A small incision is made near the joint, and an arthroscope is inserted to visualize the joint's interior. Instruments can be launched through additional small incisions for repairs. Minimally invasive techniques result in smaller incisions compared to traditional open surgery, leading to reduced scarring and less tissue trauma. Patients often experience less post-operative pain and discomfort, as the trauma to surrounding tissues is minimized. Recovery times are typically shorter, allowing patients to return to their normal activities more quickly. The risk of blood loss is generally lower due to the smaller incisions and precise visualization. Smaller incisions and reduced exposure of internal tissues can lead to a lower risk of infection. In many cases, patients require shorter hospital stays, leading to cost savings and less disruption to daily life. This factor will accelerate the demand of the Global Adhesion Barrier Market.
Download Free Sample Report
Key Market Challenges
Efficacy and Longevity
The effectiveness of adhesion barriers in preventing adhesions and their ability to maintain their performance over time are critical factors for their successful adoption and use. Adhesion barriers are designed to prevent the formation of adhesions between tissues, which can cause complications and lead to various health issues. Ensuring that adhesion barriers effectively fulfill their intended purpose is of utmost importance. Patients can respond differently to adhesion barriers due to factors such as their health status, genetics, and surgical history. This variability in response can impact the overall effectiveness of the barrier. The complexity of surgical procedures can influence the efficacy of adhesion barriers. More complex surgeries might pose challenges in proper barrier placement or adherence, affecting their performance. The location of the surgery and the type of tissues involved can impact the barrier's effectiveness. Some surgical sites may be more prone to adhesion than others. Adhesion barriers are meant to prevent adhesions during the critical healing phase after surgery. Ensuring that they remain effective throughout the entire healing process is essential to prevent late-onset complications. Some adhesion barriers are designed to degrade or be absorbed by the body over time. Balancing material degradation with the barrier's effectiveness and durability can be challenging.
Adverse Events and Side Effects
Indeed, adverse events and side effects are significant challenges in the global adhesion barrier market. Adhesion barriers, like any medical intervention, can potentially lead to unwanted reactions or complications. Managing and minimizing adverse events and side effects is crucial for the successful adoption and utilization of adhesion barrier products. Adverse events refer to any unexpected and undesirable outcome associated with the use of a medical product. The use of foreign materials can increase the risk of infections at the surgical site. Some patients may experience an inflammatory response to the adhesion barrier material. Allergic reactions to certain materials can lead to discomfort and complications. Adhesion barriers might move from their intended position, potentially causing issues in surrounding tissues. In rare cases, the adhesion barrier material itself could cause obstruction or other complications. The presence of foreign materials, such as adhesion barriers, within the body can trigger various reactions. The body's response to these materials can vary, and in some cases, it might lead to inflammation or other undesirable effects. Adhesion barrier materials need to be carefully selected to ensure they are biocompatible with the patient's body. Incompatibility can lead to adverse reactions, complications, and suboptimal healing. Patients have unique medical histories, genetic backgrounds, and responses to treatment. This clinical variability can contribute to variations in how patients react to adhesion barriers.
Key Market Trends
Advancements in Material Science
Modern materials are designed to interact harmoniously with the body's tissues, minimizing the risk of adverse reactions, inflammation, or rejection. Improved biocompatibility leads to better patient outcomes and reduced complications.
Segmental Insights
Product Insights
In 2022, the Global Adhesion Barrier was dominated by the Synthetic adhesion barrier and is predicted to continue expanding over the coming years.
Formulation Insights
In 2022, the Global Adhesion Barrier was dominated by film/mesh segment and is predicted to continue expanding over the coming years.
Application Insights
In 2022, the Global Adhesion Barrier was dominated by cardiovascular surgeries segment and is predicted to continue expanding over the coming years.
Download Free Sample Report
Regional Insights
The North America region has established itself as the leader in the Global Adhesion Barrier in 2022
Recent Developments
- In June 2022, CGBIO a company that specializes in the development of biologic medicinal products, has entered the Indonesian market through the introduction of its fourth-generation solvent-gel type antigens. At room temperature, MEDICLORE exists in the liquid form'sol', and upon application to the skin changes into a highly viscous 'gel' state based on body temperature. This is because MEDICLORE acts as a physical barrier to prevent adhesion in the area it is expected to be applied to after surgery while the wound heals. It can be employed in a variety of surgical procedures, including spinal, joint, and mastectomy operations, as well as in obstetrics and gynaecology, prostatic resection, and gastrointestinal surgery. MEDICLORE is composed of two active ingredientsPoloxamer, which acts as a physical barrier, while Chitosan, which aids in the rapid recovery of tissues without infection due to its antibacterial and haemostatic properties. Poloxamer is responsible for the direct inhibition of adhesion through a temperature dependent change process. Chitosan is responsible for the immediate recovery of tissues.
- In February 2022, Gunze Limited, a subsidiary of Osaka-Gunze Limited, has been granted medical device approval for the production and sale of TENALAF™, the world's first absorbable sheet-type adhesion barrier manufactured in Japan, which was launched on the Japanese market in March 2022 through its subsidiary "Gunze Medical Japan". Gunze’s absorbable adhesive barrier was developed with the aim of providing a cutting-edge solution in the field of adhesion. The absorbable barrier was developed through the application of proprietary absorbable technology to the absorbable material. This device offers surgeons a novel solution during open or minimally invasive surgeries, which facilitates easy manipulation, offers moderate adhesive strength to reposition, and can be placed in a conformable position. Gunze is committed to increasing its recognition by communicating the new product characteristics and advantages to surgeons and to their patients.
- In 2020, Johnson & Johnson Medical Devices Companies announced that Ethicon, has been granted 510(c) clearance by the United States Food and Drug administration (FDA). This clearance is granted to Ethicon for the development and commercialization of a novel, airless spray device (VISTASEAL) that combines biologic components with device technology for the treatment of mild-to-moderate surgical bleeding. This device is designed to be used in the open or laparoscopic setting and is composed of two Dual Applicators, one measuring 35 cm and one measuring 45 cm.
Key Market Players
·
·
·
·
·
·
·
·
·
·
| By Product | By Formulation | By Application | By Region |
| • Synthetic Adhesion Barriers • Natural Adhesion Barriers | • Film/Mesh • Gel • Liquid
| • Gynecological surgeries • Abdominal general surgeries • Orthopedic surgeries • Cardiovascular surgeries • Neurological surgeries • Urological surgeries • others
| • Asia Pacific • North America • Europe • Middle East & Africa • South America |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy